Extrathoracic Accesses in TAVI: New Standards?

Agustin Vecchia, Paolo Cioffi

Abstract


Transcatheter aortic valve implantation (TAVI) has becomein recent years a safe and efficient treatment formost patients with symptomatic severe aortic stenosis,regardless of the risk group to which they belong. Thetransfemoral access (TF) has been largely responsiblefor this success and has become the “gold standard”, inaddition to being the most frequently used.

References


Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016;374:1609–20. http://doi.org/10.1056/NEJMoa1514616

Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial. JACC Cardiovasc Interv 2017;10:2414–22. http://doi.org/10.1016/j.jcin.2017.09.023

Dahle TG, Kaneko T, McCabe JM. Outcomes Following Subclavian and Axillary Artery Access for Transcatheter Aortic Valve Replacement: Society of the Thoracic Surgeons/American College of Cardiology TVT Registry Report. JACC Cardiovasc Interv 2019;12:662–9. http://doi.org/10.1016/j.jcin.2019.01.219

Beurtheret S, Karam N, Resseguier N, Houel R, Modine T, Folliguet T, et al. Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2019;74:2728–39. http://doi.org/10.1016/j.jacc.2019.09.054

Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med 2019;380:1695–705. http://doi.org/10.1056/NEJMoa1814052

Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med 2019;380:1706–115.http://doi.org/10.1056/NEJMoa1816885

Wood DA, Lauck SB, Cairns JA, Humphries KH, Cook R, Welsh R, et al. The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study. JACC Cardiovasc Interv. 2019;12: 459–469. doi:10.1016/j.jcin.2018.12.020

Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, et al. SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve. Circulation. 2017;135:1123–32. http://doi.org/10.1161/CIRCULATIONAHA.116.025103

Auffret V, Lefevre T, Van Belle E, Eltchaninoff H, Iung B, Koning R, et al. Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol 2017;70:42–55. http://doi.org/10.1016/j.jacc.2017.04.053

Arnett DM, Lee JC, Harms MA, Kearney KE, Ramos M, Smith BM, et al. Caliber and fitness of the axillary artery as a conduit for large-bore cardiovascular procedures. Catheter Cardiovasc Interv 2018;91:150–6. http://doi.org/10.1002/ccd.27416

Schäfer U, Ho Y, Frerker C, Schewel D, Sanchez-Quintana D, Schofer J, et al. Direct Percutaneous Access Technique for Transaxillary Transcatheter Aortic Valve Implantation: “The Hamburg Sankt Georg Approach.” JACC Cardiovasc Interv 2012;5:477–86. http://doi.org/10.1016/j.jcin.2011.11.014

Schäfer U, Deuschl F, Schofer N, Frerker C, Schmidt T, Kuck KH, et al. Safety and efficacy of the percutaneous transaxillary access for transcatheter aortic valve implantation using various transcatheter heart valves in 100 consecutive patients. Int J Cardiol 2017;232:247–54. http://doi.org/10.1016/j.ijcard.2017.01.010

Mathur M, Krishnan SK, Levin D, Aldea G, Reisman M, McCabe JM. A Step-by-Step Guide to Fully Percutaneous TransaxillaryTranscatheter Aortic Valve Replacement. Structural Heart 2017;1:209–15. http://doi.org/10.1080/24748706.2017.1370156

Fröhlich GM, Baxter PD, Malkin CJ, Scott DJA, Moat NE, Hildick-Smith D, et al. Comparative survival after transapical, direct aortic,and subclavian transcatheter aortic valve implantation (data from the UK TAVI registry). Am J Cardiol 2015;116:1555–9. http://doi.org/10.1016/j.amjcard.2015.08.035

Gleason TG, Schindler JT, Hagberg RC, Deeb GM, Adams DH,Conte JV, et al. Subclavian/Axillary Access for Self-Expanding TranscatheterAortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. Ann Thorac Surg. 2018;105:477–83. http://doi.org/10.1016/j.athoracsur.2017.07.017

Amat-Santos IJ, Rojas P, Gutiérrez H, Vera S, Castrodeza J, Tobar J, et al. Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral. CatheterCardiovasc Interv 2018;92:935–44. http://doi.org/10.1002/ccd.27485

van der Wulp K, Thijs I, van Wely M, Loverbos A, Gehlmann H,Verkroost M, et al. Incidence and predictors of vascular complications in transaxillary TAVI. EuroIntervention. 2020;15:e1325–31. http://doi.org/10.4244/EIJ-D-19-00588

Wassef AWA, Rodes-Cabau J, Liu Y, Webb JG, Barbanti M,

Muñoz-García AJ, et al. The Learning Curve and Annual Procedure Volume Standards for Optimum Outcomes of Transcatheter Aortic Valve Replacement: Findings From an International Registry. JACC Cardiovasc Interv 2018;11: 1669–79. http://doi.org/10.1016/j.jcin.2018.06.044

Modine T, Lemesle G, Azzaoui R, Sudre A. Aortic valve implantation with the CoreValve ReValving System via left carotid arteryaccess: first case report. J Thorac Cardiovasc Surg2010;140: 928–9.http://doi.org/10.1016/j.jtcvs.2010.03.001

Chamandi C, Abi-Akar R, Rodés-Cabau J, Blanchard D, Dumont E, Spaulding C, et al. Transcarotid Compared With Other Alternative Access Routes for Transcatheter Aortic Valve Replacement. CircCardiovasc Interv 2018;11:e006388. http://doi.org/10.1161/CIRCINTERVENTIONS.118.006388

Verhoye J-P, Belhaj Soulami R, Tomasi J, Di Perna D, Leurent G, Rosier S, et al. Early outcomes of transcarotid access for transcatheter aortic valve implantation. EuroIntervention. 2020;15:e1332–4. http://

doi.org/10.4244/EIJ-D-18-01192

Debry N, Trimech TR, Gandet T, Vincent F, Hysi I, Delhaye C, et al. Transaxillary compared with transcarotid access for TAVR: a propensity-matched comparison from a French multicenter registry. EuroIntervention 2020. http://doi.org/10.4244/EIJ-D-20-00117

Benamer H, Auffret V, Cayla G, Chevalier B, Dupouy P,

Eltchaninoff H, et al. Position paper of French Interventional Group (GACI) for TAVI in France in 2018. Ann Cardiol Angeiol 2018;67:455-65. http://doi.org/10.1016/j.ancard.2018.09.021

Greenbaum AB, O’Neill WW, Paone G, Guerrero ME, Wyman JF, Cooper RL, et al. Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience. J Am Coll Cardiol 2014;63:2795–804. http://doi.org/10.1016/j.jacc.2014.04.015

D’Onofrio A, Colli A, Gerosa G. Percutaneous access, no matter what! J Am Coll Cardiol 2015;309–310. Percutaneous access, no matter what! J Am Coll Cardiol 2015;65:309–10. http://doi.org/10.1016/j.jacc.2014.09.085

Greenbaum AB, O’Neill WW, Paone G, Lederman RJ. Reply: percutaneous access, no matter what! J Am Coll Cardiol 2015;65:310–1.http://doi.org/10.1016/j.jacc.2014.10.038

Greenbaum AB, Babaliaros VC, Chen MY, Stine AM, Rogers T, O’Neill WW, et al. Transcaval Access and Closure for Transcatheter Aortic Valve Replacement: A Prospective Investigation. J Am Coll Cardiol 2017;69:511–21. http://doi.org/10.1016/j.jacc.2016.10.024

Costa G, De Backer O, Pilgrim T, Kasel M, Redwood S, Aminian A, et al. Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry. EuroIntervention.2020;15: e1319-24. http://doi.org/10.4244/EIJ-D-19-00797


Full Text

Refbacks

  • There are currently no refbacks.


Licencia Creative Commons
The documents published in this journal are under the licencia Creative Commons Atribución-NoComercial-Compartir-Igual 2.5 Argentina.

Revista argentina de cardiología. ISSN en línea 1850-3748. Argentine journal of cardiology (English ed. Online ISSN 2314-2286) Sociedad Argentina de Cardiología. Azcuénaga 980 (C1115AAD),Ciudad Autónoma de Buenos Aires, República Argentina. Tel. (54 11) 4961-6027/8/9 Fax: 4961-6020 www.sac.org.ar revista@sac.org.ar